Comparative efficacy evaluation of seven commercial injectable ceftriaxone purchased at Ambo, Oromia Regional State, Ethiopia, using agar well plate diffusion method

Journal of Pharmaceutical Health Services Research

Volumn 6, Issue 2, 2015, Pages 97-101

  Gunasekaran, Thirumurugan ^a   Desta, Engda Dinku ^a   Seifu, Muluneh Fromsa ^a   Gelaw, Belayneh Kefale ^a   G/Mariam, Esayas Tadesse ^a   Ahmed, Mustefa ^a  

^a AMBO UNIVERSITY   (Ethiopia)

Author keywords

Agar well plate diffusion technique; Comparative antibacterial efficacy; Injectable ceftriaxone

Indexed keywords

CEFTRIAXONE;

AGAR DIFFUSION; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BIOEQUIVALENCE; COMPARATIVE EFFECTIVENESS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DETERMINATION; ESCHERICHIA COLI; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SALMONELLA ENTERICA SEROVAR TYPHI; STANDARDIZATION; STAPHYLOCOCCUS AUREUS;

EID: 84929271678     PISSN: 17598885     EISSN: 17598893     Source Type: Journal    
DOI: 10.1111/jphs.12095     Document Type: Article

References (10)

1. Thirumurugan G etal. In-vitro evaluation of anti-bacterial activity of silver nanoparticles synthesized by using phytophthora infestans. Int J Chem Technol Res 2009; 1: 571-573.
2. Thirumurugan G etal. Superior wound healing effect of topically delivered silver nanoparticle formulation using eco-friendly potato plant pathogenic fungus: synthesis and characterization. J Biomed Nanotechnol 2011; 7: 659-666.
3. WHO. Fact Sheet No. 275. Substandard and Counterfeit Medicines. Geneva: World Health Organization, 2003.
4. Thirumurugan G etal. Silver nanoparticles as real topical bullets for wound healing. J Am Coll Clin Wound Spec 2012; 3: 82-96.
5. Finney D. Principles and planning of bio-assay. J Hyg Epidemiol Microbiol Immunol 1961; 5: 224-240.
6. Thirumurgan G, Dhanaraju MD. Biogenic metal nanoparticles: a novel biological approach for pharmaceutical applications. Adv Sci Lett 2011; 4: 339-348. doi: 10.1166/asl.2011.1246.
7. Jones RN etal. In vitro potency evaluations of various piperacillin/tazobactam generic products compared with the contemporary branded (Zosyn®, Wyeth) formulation. Diagn Microbiol Infect Dis 2008; 61: 76-79.
8. Masood SH, Aslam N. In vitro susceptibility test of different clinical isolates against Ceftriaxone. Oman Med J 2010; 25: 199-202.
9. Thapa B, Mahat K. In-vitro activity of three brands of Ceftriaxone against different clinical isolates. J Nepal Med Assoc 2010; 49: 225-227.
10. Humza AU et al. In-vitro comparative study of various brands against Pseudomonas aeruginosa. IRJP 2013; 4: 135-137.